BioSpace News Archive

Join a discussion on these and other challenges facing precision medicine at the 2018 Precision Medicine World Conference.

The deal allows Predictive Technology Group to develop, launch, and grow its services directed at limiting disease and improving the health and well-being of individuals confronting a wide-range of medical conditions.

The cash will fuel the launch of the world’s first wireless, micro-technology, drug-free neuromodulation device for relief of chronic pain.

MCRA has announced its role in the successful de novo clearance by the FDA on December 28, 2017 enabling SANUWAVE Health to initiate commercialization of the dermaPACE System for the treatment of Diabetic Foot Ulcers in the U.S.

The agreement between UBI and HKSAR for financing the project is fully effective, with total financing about HK$6,000,000.

California Life Sciences Association today issued the following statement applauding Governor Jerry Brown’s 2018 – 2019 California budget proposal that calls for $30 million to be invested in precision medicine research and the establishment of the California Institute to Advance Precision Health and Medicine (CIAPHM).

The FDA voted six in favor and thirteen against the benefit/risk profile of TLANDO.

PharMEDium is voluntarily expanding the recall issued on December 27, 2017 to include the below lots of sterile drug products to the hospital/user level due to a lack of assurance of sterility.

The Bonnie J. Addario Lung Cancer Foundation and the American Lung Association’s LUNG FORCE welcome the International Association for the Study of Lung Cancer as a new member of the Lung Cancer Patient Registry.

Diamond Light Source (Diamond) and the Structural Genomic Consortium (SGC) Oxford announced today that Enamine, a chemical company and producer of novel chemical building blocks and screening libraries, will become a key supplier of poised fragment and analogue libraries to its XChem facility. Enamine will offer a new generation of the hit-finding library, Diamond-SGC-iNEXT (DSI) Poised Library to enable fast and productive fragment-based lead discovery (FBLD).